摘要
目的分析重庆及周边患者泌尿生殖系统解脲支原体（Uu）及人型支原体（Mh）感染情况和药物耐受性特点。方法分析2010～2011年该院皮肤性病科实验室对1189例非淋菌性尿道（宫颈）炎（NGU）患者进行的支原体培养及药敏试验。结果1189例患者中支原体培养阳性555例，检出阳性率为46．7％，其中单纯Uu阳性标本386例（69．5％），Uu＋Mh混合感染157例（28．3％），单纯Mh阳性12例（2．2％）。12种抗茵药物中对支原体敏感度最高的是交沙霉素（96．0％），其次是米诺环素（95．5％）、强力霉素（94．4％）和四环素（84．0％），其余敏感度均低于60．0％。结论支原体在体外对多种抗茵药物耐药现象严重，治疗宜首选交沙霉素、米诺环素、强力霉素和四环素。
Objective To investigate the infection and antibiotic sensitivity of myeoplasma in patients with urogenital infection, and provide evidence for using antibiotics. Methods From 2010 to 2011 ,retrospective study was done on 1189 cases of culture and drug susceptibility analysis of mycoplasma in patients with urogenital infection in Chongqing. Results Among 1 189 cases of NGU, myeoplasma positive rate was 46.7% ,Uu positive were 386 cases （positive rate 69.5%） ,Uu＋Mh Positive were 157 cases （positive rate 28.3% ） ,and Mh positive were 12 eases （positive rate 2.2% ）. The highest susceptibility rate of mycoplasma to twelve kinds of antimicrobial agents was Jos（96.0%） ,the second was Min（95.5%） ,then Dox（94.4%） and Tet（84.0%）. The rest of the sensi- tivity were below 60.0 %. Conclusion Mycoplasma has a high rate of drug-resistance to multiple antibiotics. Jos, Min,Dox and Tet are the first choice to treat urogenital tract infection myeoplasma.
出处
《国际检验医学杂志》
CAS
2014年第1期58-59,共2页
International Journal of Laboratory Medicine
关键词
解脲支原体
支原体
人型
微生物敏感性试验
ureaplasma urealyticum
mycoplasma hominis
microbial sensitivity tests
